Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography
Visceral leishmaniasis, a disease caused by Leishmania infantum chagasi, represents a major public health problem in many areas of the world. Despite the considerable effort, there is no effective and safe vaccine for human use [1]. Some authors have reported that as much as 50% of overall costs in...
Na minha lista:
Principais autores: | , , , , , |
---|---|
Formato: | article |
Idioma: | English |
Publicado em: |
BMC
|
Assuntos: | |
Endereço do item: | https://repositorio.ufrn.br/handle/123456789/32543 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
id |
ri-123456789-32543 |
---|---|
record_format |
dspace |
spelling |
ri-123456789-325432021-05-21T01:52:32Z Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography Santos, Everaldo Silvino dos Sousa Junior, Francisco Canindé de Vaz, Michelle Rossana Ferreira Padilha, Carlos Eduardo de Araújo Martins, Daniella Regina Arantes Macedo, Gorete Ribeiro de Visceral Leishmaniasis Leishmaniasis Elution Condition Batch Adsorption Experiment Leishmania Infantum Visceral leishmaniasis, a disease caused by Leishmania infantum chagasi, represents a major public health problem in many areas of the world. Despite the considerable effort, there is no effective and safe vaccine for human use [1]. Some authors have reported that as much as 50% of overall costs in the biotechnology industries are related to downstream processing. Thus, the development of new and economically advantageous purification methods is a challenge [2]. Expanded bed adsorption (EBA) is an innovative chromatography technology that allows the adsorption of target proteins directly from unclarified feedstock. EBA technology combines solid-liquid separation with an adsorption step in a single-unit operation, aiming at increased overall yield, reduced operational time, and less capital investment and consumables [3,4]. Thus, the aim of this work was to purify the 503 antigen of Leishmania i. chagasi directly from crude feedstock using EBA chromatography 2021-05-21T01:52:31Z 2021-05-21T01:52:31Z 2014-10-01 article SOUSA JUNIOR, Francisco Canindé de; VAZ, Michelle Rossana Ferreira; PADILHA, Carlos Eduardo de Araújo; MARTINS, Daniella Regina Arantes; MACEDO, Gorete Ribeiro de; SANTOS, Everaldo Silvino dos. Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography. Bmc Proceedings, [S.L.], v. 8, n. 4, out. 2014. Disponível em: https://bmcproc.biomedcentral.com/articles/10.1186/1753-6561-8-S4-P194. Acesso em: 08 abr. 2021. https://doi.org/10.1186/1753-6561-8-S4-P194 1753-6561 https://repositorio.ufrn.br/handle/123456789/32543 10.1186/1753-6561-8-S4-P194 en Attribution 3.0 Brazil Attribution 3.0 Brazil http://creativecommons.org/licenses/by/3.0/br/ http://creativecommons.org/licenses/by/3.0/br/ application/pdf BMC |
institution |
Repositório Institucional |
collection |
RI - UFRN |
language |
English |
topic |
Visceral Leishmaniasis Leishmaniasis Elution Condition Batch Adsorption Experiment Leishmania Infantum |
spellingShingle |
Visceral Leishmaniasis Leishmaniasis Elution Condition Batch Adsorption Experiment Leishmania Infantum Santos, Everaldo Silvino dos Sousa Junior, Francisco Canindé de Vaz, Michelle Rossana Ferreira Padilha, Carlos Eduardo de Araújo Martins, Daniella Regina Arantes Macedo, Gorete Ribeiro de Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
description |
Visceral leishmaniasis, a disease caused by Leishmania infantum chagasi, represents a major public health problem in many areas of the world. Despite the considerable effort, there is no effective and safe vaccine for
human use [1]. Some authors have reported that as much as 50% of overall costs in the biotechnology industries are related to downstream processing. Thus, the development of new and economically advantageous purification methods is a challenge [2]. Expanded bed adsorption (EBA) is an innovative chromatography technology that allows the adsorption of target proteins directly from unclarified feedstock. EBA technology combines solid-liquid separation with an adsorption step in a single-unit operation, aiming at increased overall yield, reduced operational time, and less capital investment and consumables [3,4]. Thus, the aim of this work was to purify the 503 antigen of Leishmania i. chagasi directly from crude feedstock using EBA chromatography |
format |
article |
author |
Santos, Everaldo Silvino dos Sousa Junior, Francisco Canindé de Vaz, Michelle Rossana Ferreira Padilha, Carlos Eduardo de Araújo Martins, Daniella Regina Arantes Macedo, Gorete Ribeiro de |
author_facet |
Santos, Everaldo Silvino dos Sousa Junior, Francisco Canindé de Vaz, Michelle Rossana Ferreira Padilha, Carlos Eduardo de Araújo Martins, Daniella Regina Arantes Macedo, Gorete Ribeiro de |
author_sort |
Santos, Everaldo Silvino dos |
title |
Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
title_short |
Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
title_full |
Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
title_fullStr |
Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
title_full_unstemmed |
Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography |
title_sort |
production, recovery, and purification of recombinant 503 antigen of leishmania infantum chagasi using expanded bed adsorption chromatography |
publisher |
BMC |
publishDate |
2021 |
url |
https://repositorio.ufrn.br/handle/123456789/32543 |
work_keys_str_mv |
AT santoseveraldosilvinodos productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography AT sousajuniorfranciscocanindede productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography AT vazmichellerossanaferreira productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography AT padilhacarloseduardodearaujo productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography AT martinsdaniellareginaarantes productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography AT macedogoreteribeirode productionrecoveryandpurificationofrecombinant503antigenofleishmaniainfantumchagasiusingexpandedbedadsorptionchromatography |
_version_ |
1773957969534255104 |